| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA654811 | F | Synergistic antiviral activity with AZT (DDI), against HIV-IIIB in C8166 cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 2. | ALA654812 | F | Synergistic antiviral activity with AZT (DDI), against HIV-IIIB in C8166 cells (combination index in association with DDI) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA654813 | F | Effective dose which reduces the HIV-1 yield in C8166 cells by 90% | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 4. | ALA654814 | F | Pprotection of C8166 cells against the cytopathic effect of HIV isolate RF | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 5. | ALA654815 | F | Protection of C8166 cells against the cytopathic effect of HIV isolate CBL-1 | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 6. | ALA654816 | F | Protection of C8166 cells against the cytopathic effect of HIV isolate RF | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA654817 | F | Antitumor activity against CD+ human acute T-lymphoblastic leukemia C8166 cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 8. | ALA654818 | F | Antitumor activity against CD4+ human acute T-lymphoblastic C8166 leukemia cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
| 9. | ALA654819 | F | Antiviral activity against HIV-1 (RF strain) in C8166 cells | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 10. | ALA654820 | F | Antiviral activity in HIV-1RF infected C8166 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA654821 | F | Concentration which results in 50% survival of uninfected untreated control C8166 cells (cytotoxicity of the compound) | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 12. | ALA877269 | A | Concentration which results in 50% survival of uninfected untreated control C8166 cells (cytotoxicity of the compound) | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 13. | ALA654822 | F | Inhibitory activity against HIV-1 IIIB replication in C8166 cells. | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 14. | ALA654118 | F | Inhibitory activity against HIV-1 IIIB replication in C8166 cells. | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 15. | ALA654119 | F | Inhibitory activity against HIV-1 IIIB replication in C8166 cells. | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 16. | ALA654120 | F | Selectivity index was determined in C8166 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA654121 | F | Inhibition of p24 antigen formation in infected C8166-cells | 9 | cell-based format | Scientific Literature | |||
| 18. | ALA654122 | F | Inhibition of syncytia formation in infected C8166-cells | 9 | cell-based format | Scientific Literature | |||
| 19. | ALA654123 | F | Selectivity index in HIV-1 infected C8166 (human CD4) cells. | 21 | cell-based format | Scientific Literature | |||
| 20. | ALA654124 | F | Selectivity index expressed as ratio of TC50 (HSV-1) to EC50 (HSV-1) in vero cells | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!